TREATMENT OUTCOME OF PROVOX 2

• Published in: JIBI INKOKA TEMBO Vol. 56; no. Supplement1; pp. s104 - s107
• Main Authors: Yoshimura, Tomonori, Tanaka, Syuhou, Ashizawa, Kei, Nakayama, Masahiro, Tabuchi, Keiji, Nakamagoe, Mariko, Hirose, Yuki, Nishimura, Bungo, Okubo, Hideki, Ohara, Hirotatsu, Wada, Tetsuro, Hara, Akira, Hoshino, Tomofumi, Uemaetomari, Isao
• Format: Journal Article
• Language: Japanese
• Published: Society of Oto-rhino-laryngology Tokyo 05.03.2013; 耳鼻咽喉科展望会
• Subjects: Provox; QOL; quality of life (QOL); tracheo-esophageal puncture (TEP); プロヴォックス; 気管食道シャント
• ISSN: 0386-9687; 1883-6429
• DOI: 10.11453/orltokyo.56.s104

A clinical analysis was conducted of seven alaryngeal patients who had undergone tracheo-esophageal puncture (TEP) with Provox® 2 over a 2-year period. The patients consisted of 6 males and 1 female, ranging in age from 49 to 83 years old (mean age, 61 years). The underlying diseases were laryngeal carcinoma in 2 cases and hypopharyngeal carcinoma in 5 cases. All the TEP procedures were performed as secondary operations under general anesthesia. The average operation time was 20 minutes (range, 7 to 43 minutes). QOL analysis was also performed using the revised edition of the Japanese Voice Handicap Index (VHI).